Moreover, loss of NHERF-1 expression in the cervical cell line promoted cellular adhesion, wound healing, and invasion, indicating NHERF-1 as a plausible therapeutic target for cervical cancer patients (72). The gene discussed is NHERF1; the disease is cervical cancer.